Gotham Asset Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
PWAM
DSCM
Gotham Asset Management's FLGT Position: Q1 2024 in Review
Gotham Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 10,717 shares — an estimated $310K sold.
Gotham Asset Management first reported a position in FLGT in Q1 2021 and held it in 12 quarters. The position peaked at $3.83M in Q2 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.
- Gotham Asset Management reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
- Gotham Asset Management sold 10,717 Fulgent Genetics shares in Q1 2024, an estimated $310K.
- Gotham Asset Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 12 quarters.
- Gotham Asset Management's Fulgent Genetics position peaked at $3.83M in Q2 2021.
- 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.
Based on Gotham Asset Management's 13F filing for Q1 2024, filed 15 May 2024.